YILING PHARMACEUTICAL(SZ:002603) Zhong Guo Jing Ji Wang·2026-01-07 02:16Core Viewpoint - Yiling Pharmaceutical's Ziziphus jujuba seed planting base has passed the GAP extension inspection by the Hebei Provincial Drug Administration, marking it as the first of its kind in the country to achieve this certification [1] Group 1: GAP Extension Inspection Results - The GAP extension inspection is a comprehensive compliance check of the entire production process of medicinal materials, ensuring safe and effective medication, promoting industry standardization, enhancing market recognition and brand value, and facilitating sustainable resource utilization [3] - Yiling Pharmaceutical's Ziziphus jujuba seed base has established and implemented a complete, standardized, and traceable quality management system throughout the processes of sourcing, planting, harvesting, processing, storage, and transportation [3] Group 2: Company and Product Information - Ziziphus jujuba is commonly used in clinical settings for treating insomnia, neurasthenia, and irritability caused by menopause, with Yiling Pharmaceutical producing various medications that utilize this ingredient [4] - Yiling Pharmaceutical has developed a standardized planting base of 4,760 acres and a wild nurturing base of 3,200.49 acres located in Nansai Township, Neiqiu County, Xingtai City, which is recognized as a geographical indication product [4][5] Group 3: Development and Economic Impact - The establishment of the base not only promotes the rapid and healthy development of the local medicinal material planting industry but also enhances the income of local farmers, transforming Ziziphus jujuba into a profitable industry [6] - Yiling Pharmaceutical adheres to a development model of "company + base + farmers," creating a new model for rural revitalization that drives industry, technology, employment, product value enhancement, and wealth creation for local communities [6]